Govt Makes Unique ID Mandatory For Doctors

New Delhi : Doctors will now have to get a Unique Identification Number (UID) to be able to practice medicine in the country, as per the new regulations by the National Medical Commission (NMC).

The UID will be generated centrally by the NMC ethics board and thereby grant the practitioner registration in NMR and eligibility to practice medicine in India.

According to the new notification by NMC, there will be a common national medical register for all the registered medical practitioners of the country. The same will be maintained by the Ethics and Medical Registration Board (EMRB) under the NMC. This register will contain all the entries of the registered medical practitioners of all State Registers maintained by the various State Medical Councils and will have all relevant information regarding the medical practitioner.

The licence to practice medicine issued to a registered medical practitioner will be valid for a period of five years after which the medical practitioner will have to renew the licencing by making an application to the State Medical Council, said the new notification-“Registration of Medical Practitioners and Licence to Practice Medicine Regulations, 2023”.

The application for renewal of licence may be made before three month of expiration of the validity of licence, it said.

  • Related Posts

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Shares of Mankind Pharma fell more than 2% on 16 October after the company announced that it has signed an agreement to acquire a 70% stake in Belgium-based biotechnology company…

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    NEW DELHI: Can a drug licensing authority suspend a pharmaceutical distributor’s licence while issuing a show-cause notice, before considering its response? The Karnataka high court has said the procedure under…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs